Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy

[1] Yannuzzi LA(1990)Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1-8

[2] Sorenson J(1997)The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 478-485

[3] Spaide RF(2003)Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392-1396

[4] Lipson B(1995)Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy Retina 15 100-110

[5] Yannuzzi LA(2004)Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576-1584

[6] Ciardella A(2008)One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmololgy 115 141-146

[7] Spaide RF(2007)Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 270-277

[8] Rabb M(2008)Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 70-73

[9] Freund KB(2008)Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Br J Ophthalmol 92 661-666

[10] Orlock DA(2009)Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 148 70-78

[1] Yannuzzi LA(1990)Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1-8

[2] Sorenson J(1997)The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 478-485

[3] Spaide RF(2003)Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392-1396

[4] Lipson B(1995)Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy Retina 15 100-110

[5] Yannuzzi LA(2004)Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576-1584

[6] Ciardella A(2008)One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmololgy 115 141-146

[7] Spaide RF(2007)Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 270-277

[8] Rabb M(2008)Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 70-73

[9] Freund KB(2008)Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Br J Ophthalmol 92 661-666

[10] Orlock DA(2009)Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 148 70-78